Advances in Breast Cancer Therapy
Abstract
PTI has received WIRB approval and the University of Pittsburgh IRB approval for this study. PTI has engaged 19 research sites in this research and four contracts have been successfully negotiated and executed. Another six research sites are determining clinical and budgetary feasibility. Pending the approval of the DoD and the WIRB of this first set of research sites submitted for approval, it is anticipated we will have the first patient enrolled in July, 2009.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2009
- Accession Number
- ADA510052
Entities
People
- Holly Gallion